Analyst expects Bruker stock to perform well in the coming months

04/11/2010 | Barrons.com

An analyst from Brean Murray Carret expects Bruker's shares to perform well in the next 12 months, driven by the company's loyal client base, technologically advanced devices and innovative efforts. Bruker BioSpin, which leads Bruker's Scientific Instruments unit, generates 40% of the company's revenue and leads the nuclear magnetic resonance spectroscopy market.

View Full Article in:

Barrons.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC